This inventor holds 1 USPTO granted patent. Top assignee: The United States of America as Represented by the Department of Health. Active years: 1994.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1994
Title: Kenneth M Snader: Innovator in Antitumor Compounds
Introduction
Kenneth M Snader is a notable inventor based in Germantown, MD (US). He has made significant contributions to the field of cancer treatment through his innovative research and development of antitumor compounds. His work is particularly focused on isolating compounds from natural sources to combat cancer effectively.
Latest Patents
Kenneth M Snader holds a patent for an antitumor compound, compositions, and methods of use. The patent describes a new antitumor compound, specifically 6(R)-bromo-3(S)-bromomethyl-7-methyl-2,3,7-trichloro-1-octene. This invention relates to a method for isolating the compound from a red alga, as well as antitumor compositions that utilize this compound for treating patients with cancer.
Career Highlights
Kenneth M Snader is associated with the United States of America as represented by the Department of Health. His work has been instrumental in advancing the understanding and treatment of cancer through innovative compounds derived from natural sources.
Collaborations
Some of his notable coworkers include Michael R Boyd and John H Cardellina, II. Their collaborative efforts have contributed to the successful development of antitumor therapies.
Conclusion
Kenneth M Snader's contributions to the field of antitumor compounds highlight the importance of innovation in cancer treatment. His work continues to inspire advancements in medical research and therapeutic applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile